| NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i |
| |
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
ARIX Bioscience PLC
|
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) |
| Non-UK issuer | |
| 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) |
| An acquisition or disposal of voting rights | |
| An acquisition or disposal of financial instruments | X |
| An event changing the breakdown of voting rights | |
| Other (please specify)iii: | |
| 3. Details of person subject to the notification obligationiv |
| Name | Weiss Asset Management LP |
| City and country of registered office (if applicable) | Wilmington, Delaware, USA |
| 4. Full name of shareholder(s) (if different from 3.)v |
| Name | Brookdale International Partners, L.P., Brookdale Global Opportunity Fund |
| City and country of registered office (if applicable) | Brookdale International Partners, L.P.: Albany, NY, USA Brookdale Global Opportunity Fund: Grand Cayman, Cayman Islands |
| 5. Date on which the threshold was crossed or reachedvi: | January-2-2024 |
| 6. Date on which issuer notified (DD/MM/YYYY): | January-4-2024 |
| 7. Total positions of person(s) subject to the notification obligation |
| | % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights of issuervii |
| Resulting situation on the date on which threshold was crossed or reached | 0.00 | 5.19 | 5.19 | 129,389,508 |
| Position of previous notification (if applicable) | N/A | N/A | N/A | |
| | | | | | | |